RINREYA
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98081534
- Registration number
- 7765100
- Mark type
- Stylized text
- Filed
- 12 Jul 2023
- Published for opposition
- 07 May 2024
- Registered
- 22 Apr 2025
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2025 — ELECTRONIC RECORD REVIEW COMPLETE
- 27 Mar 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 27 Mar 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 10 May 2024 — NOTICE OF ALLOWANCE CANCELLED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2024 — SOU EXTENSION 1 GRANTED
- 30 Dec 2024 — SOU EXTENSION 1 FILED
- 30 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 May 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED